Manufacturers who use red no. 3 in food and and ingested drugs will have until January 15, 2027 or January 18, 2028, respectively, to reformulate their products. The FDA has revoked the authorization ...

Colleen Sloan, PA-C, RDN, explores how diet can help manage childhood constipation. "She's so constipated. I give her a laxative, and she eats fruit. What else can I do?" This familiar concern echoes ...

Across all years in the report, the CDC rated each physical activity trend included with a color of red, indicating that trend is going in the "wrong direction." The Youth Risk Behavior Survey (YRBS) ...

According to the report, several key dietary behaviors such as daily fruit or vegetable intake among high school students were trending in the wrong direction. The Centers for Disease Control and ...

Of those with a minimum age or minimum interval vaccine dose, 44.9% ended up receiving extra doses to complete a vaccination series. Vaccine doses provided to children outside of the CDC's Advisory ...

The lead clinical trial investigator for a phase 3 study of crinecerfont in pediatric CAH patients breaks down the December 2024 FDA approval. The FDA approval of crinecerfont (Crenessity; Neurocrine ...

Principal investigator Lewis Romer, MD, of Johns Hopkins Medicine joined us to discuss the actively-recruiting MoD PAH trial assessing mono vs dual therapy for pediatric PAH. Lewis Romer, MD, ...

Neffy was first approved in September 2024 to treat type 1 allergic reactions in patients who weigh at least 66 lbs (33 kg). ARS Pharmaceuticals has announced new developments for neffy (epinephrine ...

Results from a recent study revealed that compulsive and addictive elements can contribute to the risk of disordered eating. Study investigator Susan Carnell, PhD, explains these findings. Carnell is ...

Positive interim data was reported from the ENERGY 1 trial and Expanded Access Program that featured a total of 5 infants and 1 child. Positive interim data from Inozyme Pharma has been reported for ...

Based on reports by NoroSTAT-participating states, the total number of outbreaks in 2024-2025 seasonal year is above the range reported 012–2020 and 2021-2024 seasonal years. From August 1, 2024, ...

In an open-label extension of the EPITOPE phase 3 trial, the Viaskin Peanut patch had continued improvement in toddlers aged 1-3 years through 36 months. Positive data from an open-label extension ...